Two women have filed a class-action lawsuit against a major breast implant maker after hundreds of Americans developed a rare cancer linked to implants

  • On August 16, two women filed a class-action lawsuit against Allergan, a major breast implant manufacturer.
  • The lawsuit comes after Allergan’s Biocell breast implants were linked to a rare form of cancer called breast implant-associated anaplastic large cell lymphoma, or BIA-ALCL.
  • Allergan voluntarily recalled the implants in July at the request of the Food and Drug Administration.
  • The women who filed the lawsuit said they wouldn’t have gotten Biocell implants if they knew about the cancer link. Neither of the women have BIA-ALCL.
  • Visit INSIDER’s homepage for more.

Less than a month after major breast implant manufacturer Allergan voluntarily recalled its Biocell breast implants, two women have filed a class action lawsuit against the company.

The women said in the lawsuit that it cost tens of thousands of dollars to get the implants in the first place, and then, in one case, get them removed out of fear of developing BIA-ALCL, a type of rare cancer linked to this specific type of implant.

One of the women hasn’t had her implants surgically removed, but said that she wouldn’t have gotten them in the first place if she knew of the BIA-ALCL risk. Neither of the women have developed BIA-ALCL.

Allergan recently recalled its Biocell breast implants

On July 24, Allergan announced it was voluntarily recalling its Biocell textured breast implants after the FDA logged hundreds of cases where women who had the implants developed BIA-ALCL.

As of September 2018, the FDA had received 457 unique reports of BIA-ALCL, including nine deaths “which may be attributable” to the cancer, according to a letter the FDA wrote to healthcare providers.

The women involved in the lawsuit are seeking monetary damages for themselves and other women with the implants because they “will be forced to expend substantial sums for the removal of the recalled implants, surgical and diagnostic fees, and/or medical monitoring and invasive diagnostic procedures required as a result of their exposure to the risk of contracting BIA-ALCL,” they said in lawsuit documents obtained by INSIDER.

Read more: Hundreds of Americans have developed a rare cancer that’s linked to breast implants, and the FDA is urging doctors to stay alert

On July 30, Allergan announced it would cover the costs of new implants for people with Biocell implants who want to replace them. Allergan won’t pay for surgery costs, however. The program runs until July 24, 2021.

“Our national class action lawsuit seeks to cover the costs associated with explanting the recalled breast implants and replacing them with non-recalled breast implants. Our clients and the many women who have contacted us should not have to deal with the anxiety of living with a recalled breast implant. We look forward to fighting on their behalf in seeking a resolution that provides them peace of mind,” said plaintiff’s attorneys Joe Sauder and Matt Schelkopf of Sauder Schelkopf.

If you’ve developed BIA-ALCL and would like to discuss your story, contact Julia Naftulin at jnaftulin@businessinsider.com.